Rethinking Long-Term Care in Canada is a new study that compares Canada to other high-income countries—Germany, Japan, the Netherlands, and Sweden—with older populations that have leveraged collaboration between the public and private sectors to better meet the needs of their elderly population, granting them more autonomy and freedom to organize their own care as they see fit.

Understanding Universal Health Care Reform Options: Activity-Based Funding is a new study that finds paying hospitals for each patient they treat, also known as activity-based funding, instead of allocating pre-defined annual budgets could improve the quantity and quality of health care services while reducing wait times for Canadians. Nearly every other developed country with a universal health-care system has moved towards activity-based funding in recent decades, whereas Canada is among the last to continue to use lump sum payments.

Timely Access to New Pharmaceuticals in Canada, the United States, and the European Union is a new study that finds Canadian patients are waiting, on average, more than 450 days longer than Americans and Europeans to access new, potentially life-saving drugs. That’s because pharmaceutical companies are reluctant to launch new drugs in Canada because of a number of factors including the smaller market size, weaker intellectual property protections, and the federal government’s strict pricing policies.